Taro Pharmaceutical Industries Ltd. Current Ratio 2010-2023 | TARO
Taro Pharmaceutical Industries Ltd. current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-12-31 | $1.35B | $0.37B | 3.60 |
| 2023-09-30 | $1.34B | $0.36B | 3.71 |
| 2023-06-30 | $1.29B | $0.39B | 3.36 |
| 2023-03-31 | $1.34B | $0.39B | 3.47 |
| 2022-12-31 | $1.39B | $0.37B | 3.72 |
| 2022-09-30 | $1.36B | $0.38B | 3.62 |
| 2022-06-30 | $1.35B | $0.37B | 3.60 |
| 2022-03-31 | $1.34B | $0.43B | 3.10 |
| 2021-12-31 | $1.24B | $0.40B | 3.13 |
| 2021-09-30 | $1.41B | $0.61B | 2.30 |
| 2021-06-30 | $1.48B | $0.73B | 2.03 |
| 2021-03-31 | $1.47B | $0.68B | 2.18 |
| 2020-12-31 | $1.52B | $0.58B | 2.61 |
| 2020-09-30 | $1.49B | $0.59B | 2.53 |
| 2020-06-30 | $1.52B | $0.60B | 2.55 |
| 2020-03-31 | $1.53B | $0.22B | 6.88 |
| 2019-12-31 | $1.46B | $0.21B | 6.81 |
| 2019-09-30 | $1.48B | $0.21B | 7.06 |
| 2019-06-30 | $1.53B | $0.19B | 8.11 |
| 2019-03-31 | $1.48B | $0.22B | 6.84 |
| 2018-12-31 | $1.46B | $0.22B | 6.69 |
| 2018-09-30 | $1.87B | $0.20B | 9.19 |
| 2018-06-30 | $1.83B | $0.19B | 9.52 |
| 2018-03-31 | $1.90B | $0.22B | 8.79 |
| 2017-12-31 | $1.91B | $0.21B | 8.93 |
| 2017-09-30 | $1.93B | $0.20B | 9.56 |
| 2017-06-30 | $1.93B | $0.21B | 9.40 |
| 2017-03-31 | $2.00B | $0.21B | 9.53 |
| 2016-12-31 | $1.78B | $0.24B | 7.44 |
| 2016-09-30 | $1.58B | $0.23B | 6.99 |
| 2016-06-30 | $1.69B | $0.24B | 6.92 |
| 2016-03-31 | $1.88B | $0.25B | 7.65 |
| 2015-12-31 | $1.88B | $0.25B | 7.65 |
| 2015-09-30 | $1.71B | $0.28B | 6.19 |
| 2015-06-30 | $1.57B | $0.25B | 6.31 |
| 2015-03-31 | $1.51B | $0.31B | 4.88 |
| 2014-12-31 | $1.35B | $0.27B | 5.07 |
| 2014-09-30 | $1.22B | $0.24B | 5.18 |
| 2014-06-30 | $1.10B | $0.25B | 4.37 |
| 2014-03-31 | $1.05B | $0.25B | 4.15 |
| 2013-12-31 | $0.98B | $0.24B | 4.01 |
| 2013-09-30 | $1.10B | $0.23B | 4.82 |
| 2013-06-30 | $0.98B | $0.21B | 4.61 |
| 2013-03-31 | $0.91B | $0.19B | 4.73 |
| 2012-12-31 | $0.84B | $0.17B | 4.84 |
| 2012-09-30 | $0.77B | $0.17B | 4.48 |
| 2012-06-30 | $0.68B | $0.16B | 4.29 |
| 2012-03-31 | $0.65B | $0.20B | 3.29 |
| 2011-12-31 | $0.58B | $0.19B | 3.05 |
| 2011-09-30 | $0.49B | $0.17B | 2.82 |
| 2011-06-30 | $0.40B | $0.13B | 2.99 |
| 2011-03-31 | $0.35B | $0.13B | 2.56 |
| 2010-12-31 | $0.29B | $0.13B | 2.17 |
| 2010-09-30 | $0.32B | $0.20B | 1.61 |
| 2010-06-30 | $0.29B | $0.22B | 1.37 |
| 2010-03-31 | $0.30B | $0.23B | 1.28 |
| 2009-12-31 | $0.27B | $0.22B | 1.23 |
| 2009-09-30 | $0.28B | $0.23B | 1.25 |
| 2009-06-30 | $0.24B | $0.19B | 1.27 |
| 2009-03-31 | $0.23B | $0.19B | 1.26 |
